Age (yr) | 0.96 (0.93–0.98) | .004a | 0.94 (0.88–0.99) | .04a |
Sex, men vs women | 0.94 (0.27–3.2) | .92b | 0.35 (0.07–1.77) | .34c |
P-GCS | 0.63 (0.5, 0.8) | <.001a | 0.78 (0.6–1) | .05 |
Motor score | 0.43 (0.25–0.76) | .003a | 0.7 (0.44–1.14) | .15 |
Systolic BP (mm Hg) | 0.99 (0.97–1) | .15 | 1.01 (0.98,1.04) | .46 |
Diastolic BP (mm Hg) | 0.99 (0.97–1.03) | .84 | 1 (0.96–1.05) | .72 |
PT (seconds) | 0.98 (0.84–1.14) | .78 | 0.93 (0.67–1.3) | .64 |
aPTT (seconds) | 1.03 (0.92–1.15) | .57 | 1 (0.85–1.18) | .93 |
Fibrinogen (mg/dL) | 0.98 (0.97–0.99) | .002a | 0.99 (0.98–1) | .06 |
Platelets (103/μL) | 1 (0.99–1.01) | .81 | 1 (0.99–1.01) | .4 |
Marshall CT score | | | | |
DI II | 1 | | 3.46 (0.55–21.9) | .2c |
DI III and 1V | 4.27 (0.9–20) | .06c | | |
Hemorrhagic progression | 1.12 (0.35–3.54) | .85b | 2.84 (0.32–25.4) | .31c |
Fraction of hemorrhagic progression | 1.02 (0.96–1.11) | .49 | 1 (0.91–1.1) | .88 |
Iodine concentration (mg/mL) | 44 (3.03–641) | .005a | 16 (0.58–442) | .1 |
Hematoma volume on admission CT (cm3) | 1.05 (0.97–1.13) | .21 | 1.04 (0.95–1.14) | .4 |
Hematoma volume on follow-up CT (cm3) | 1.06 (1–1.12) | .04a | 1.04 (0.99–1.1) | .1 |
Total pseudohematoma from all contusions (cm3) | 1.32 (1.06–1.64) | .01a | 1.1 (0.99–1.23) | .06 |
Fractional pseudohematoma to true hematoma | 2.66 (0.6–11.8) | .19 | 2.43 (0.3–18.9) | .39 |
Iodine quantity in all pseudohematomas (mg) | 1.48 (1.04–2.11) | .03a | 1.04 (0.96–1.13) | .3 |
Iodine quantity in all contusions (mg) | 1.1 (1.01–1.21) | .02a | 1.03 (0.98–1.08) | .15 |